Abstract:A high-fat diet (HFD) has been associated with various adverse health outcomes, including cognitive impairment and an elevated risk of neurodegenerative conditions. This relationship is partially attributed to the influence of an HFD on the gut microbiota. The objective of this research was to evaluate the neuroprotective benefits of co-fermented black barley and quinoa with Lactobacillus (FG) against cognitive impairments triggered by a HFD, and to investigate the microbiota-gut-brain axis mechanisms involved. C57BL/6J mice were randomized into four groups: the normal control group (NC, n=10), the high-fat diet group (HFD, n=10), the high-fat diet group supplemented with FG (HFG, 10 mL/kg·BW, n=10), and the high-fat diet group supplemented with Lactobacillus (HFL, 10 mL/kg·BW, n=10). Our results showed that the FG intervention enhanced the behavioral and locomotor skills of mice, elevated the levels of dopamine (DA) and norepinephrine (NPI) in brain tissues, and alleviated synaptic ultrastructural damage in the hippocampus. Furthermore, FG intervention was observed to exert a protective effect on both the blood-brain barrier and the colonic barrier, as evidenced by an increase in the mRNA levels of Zona occludens1(ZO-1), Claudin-4, and Occludin in the hippocampus and colon. These beneficial effects may be attributed to FG's regulation of gut microbiota dysbiosis, which involves the restoration of intestinal flora diversity, reduction of the Firmicutes/Bacteroidetes (F/B) ratio, and decrease in levels of pro-inflammatory bacteria such as s_Escherichia coli E and g_Escherichia; moreover, there was an increase in the abundances of anti-inflammatory bacteria, such as s_Bacteroides thetaiotaomicron and s_Parabacteroides goldsteinii. Metagenomic analysis revealed that the FG treatment downregulated the lipopolysaccharide (LPS) pathway and upregulated of neurotransmitter biosynthetic pathways. These probiotic effects of FG resulted in reduced production and "leakage" of LPS, and decreased mRNA expression of Toll-like receptor 4 (Tlr4), cluster of differentiation 14 (CD14), and myeloid differentiation factor 88 (Myd88) in hippocampus and colon tissues. Consequently, a reduction was observed in the levels of inflammatory cytokines in the serum, hippocampus, and colon, along with a suppression in the immunoreactivity of microglia and astrocytes. Our results suggested that FG may serve as an intervention strategy for preventing cognitive impairments caused by HFD.

Amelioration of cognitive impairment using epigallocatechin-3-gallate in ovariectomized mice fed a high-fat diet involves remodeling with Prevotella and Bifidobacteriales

EGCG Ameliorates High-Fat- and High-Fructose-induced Cognitive Defects by Regulating the IRS/AKT and ERK/CREB/BDNF Signaling Pathways in the CNS

The co-fermentation of whole grain black barley and quinoa improves murine cognitive impairment induced by a high-fat diet via altering gut microbial ecology and suppressing neuroinflammation

Green Tea Catechin Epigallocatechin Gallate Alleviates High‐fat Diet‐induced Obesity in Mice by Regulating the Gut–brain Axis

Effects of (−)-Epigallocatechin Gallate (EGCG) on Energy Expenditure and Microglia-Mediated Hypothalamic Inflammation in Mice Fed a High-Fat Diet

Gut Prevotellaceae-GABAergic Septohippocampal Pathway Mediates Spatial Memory Impairment in High-Fat Diet-Fed Ovariectomized Mice

Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice

Supplementation with a Novel Combination of Fruits and Vegetables Prevented High Fat Diet-Induced Cognitive Impairment in Mice

Epigallocatechin-3-gallate alleviates-galactose-induced aging impairment via gut-brain communication

Chlorogenic Acid Ameliorates High-Fat and High-Fructose Diet- Induced Cognitive Impairment Via Mediating the Microbiota-Gut- Brain Axis

EGCG Regulates Fatty Acid Metabolism of High-Fat Diet-Fed Mice in Association with Enrichment of Gut Akkermansia Muciniphila

Fermented Gastrodia elata Bl. Alleviates Cognitive Deficits by Regulating Neurotransmitters and Gut Microbiota in D-Gal/AlCl3-Induced Alzheimer's Disease-like Mice

Promotion of neuroinflammation by the glymphatic system: a new insight into ethanol extracts from Alisma orientale in alleviating obesity-associated cognitive impairment

Secoisolariciresinol diglucoside attenuates neuroinflammation and cognitive impairment in female Alzheimer's disease mice via modulating gut microbiota metabolism and GPER/CREB/BDNF pathway

Metagenomics Analysis of Gut Microbiota in a High Fat Diet-Induced Obesity Mouse Model Fed with (-)-Epigallocatechin 3-O-(3-O-Methyl) Gallate (EGCG3″Me)

Influence of estrogen on the cognition in D-galactose-induced ovariectomized mice and their apoE-knock-out mice

Epigallocatechin Gallate (EGCG) Promotes the Immune Function of Ileum in High Fat Diet Fed Mice by Regulating Gut Microbiome Profiling and Immunoglobulin Production.

Secoisolariciresinol Diglucoside Attenuates Neuroinflammation and Cognitive Impairment in Female Alzheimer’s Disease Mice Via Modulating Gut Microbiota Metabolism and GPER/CREB/BDNF Pathway

Epigallocatechin-3-Gallate Attenuates Impaired Cognitive Function Induced by Chronic Cerebral Hypoperfusion Via Activating HO-1 Through PI3K/Akt/Nrf2 Signaling Pathway

Iron Chelation Remits Memory Deficits Caused by the High-Fat Diet in a Mouse Model of Alzheimer's Disease

17β-Estradiol Modulates SIRT1 and Halts Oxidative Stress-Mediated Cognitive Impairment in a Male Aging Mouse Model